News

GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity. Acorda Therapeutics had submitted an IND

EMD Chemicals said that the StemSelect Library I is an expert selection of 303 pharmacologically active, cell-permeable (or cell receptor binding) InSolution modulators, many of which act in

Immunomedics had recently developed a new serum-based enzyme immunoassay (ELISA) for early diagnosis of pancreatic cancer, employing clivatuzumab that has a sensitivity of 62% for detecting stage-1 pancreatic

The new test is based upon a plasma biomarker discovered by R&D Antibodies that forecasts the onset of the sepsis pathology. In previous clinical studies the test was

ForteBio claimed that Octet QK(e) system would enable biosensors to be re-racked, for increased workflow flexibility and cost savings. ForteBio has also introduced latest Anti-Penta-HIS (HIS) biosensors for

Mr Guay is a chartered accountant since 1974 and has a number of years of experience in business management. During his career, he has worked for such companies

IOBS are a relatively new classification of pathogen detection equipment that use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens. These devices

Abbott has posted a net income of $1bn for the first quarter 2010, or $0.64 per diluted share, a decrease of 30.3%, compared to $1.43bn, or $0.92 per

The Advia Chemistry Ecstasy assay allows the choice of two cut-off values (300ng/ml and 500ng/ml), complying with both the latest Samhsa1 recommendations as well as EWDTS2 guidelines. The